StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) stock

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.91−0.11 (-3.64%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

Galectin Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for Galectin Therapeutics

Galectin Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Galectin Therapeutics figures

See a number that looks wrong?